Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Operating Leases (2020 - 2023)

Agilon Health (AGL) has disclosed Operating Leases for 4 consecutive years, with $10.5 million as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, Operating Leases rose 26.67% year-over-year to $10.5 million, compared with a TTM value of $10.5 million through Mar 2023, up 26.67%, and an annual FY2022 reading of $9.9 million, up 25.06% over the prior year.
  • Operating Leases was $10.5 million for Q1 2023 at Agilon Health, up from $9.9 million in the prior quarter.
  • Across five years, Operating Leases topped out at $11.0 million in Q2 2022 and bottomed at $5.3 million in Q2 2021.
  • Average Operating Leases over 4 years is $8.2 million, with a median of $8.1 million recorded in 2021.
  • Peak annual rise in Operating Leases hit 106.51% in 2022, while the deepest fall reached 25.06% in 2022.
  • Year by year, Operating Leases stood at $5.5 million in 2020, then skyrocketed by 43.5% to $7.9 million in 2021, then grew by 25.06% to $9.9 million in 2022, then grew by 5.95% to $10.5 million in 2023.
  • Business Quant data shows Operating Leases for AGL at $10.5 million in Q1 2023, $9.9 million in Q4 2022, and $10.3 million in Q3 2022.